Navigation Links
Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels
Date:7/5/2009

f blood vessels containing lesions with dramatically reduced levels of myocardin. GICD then looked at levels of miR-143 and miR-145 in this disease setting. The team in Rochester also did experiments to show that local delivery of miR-145 in mouse blood vessels leads to elevated expression of myocardin and its target genes.


'/>"/>

Contact: Greg Williams
Greg_Williams@urmc.rochester.edu
585-273-1757
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Rare sheep could be key to better diagnostic tests in developing world, says Stanford study
2. Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study
3. Overweight kids experience more loneliness, anxiety, MU study finds
4. Children with autism need to be taught in smaller groups, pilot study confirms
5. Predicting the return of prostate cancer: New Johns Hopkins study betters the odds of success
6. Study Casts Doubt on Low IQs Role in Early Death
7. Study shows PET can measure effectiveness of novel breast cancer treatment
8. New Study Shows Many Unplanned Quit Smoking Attempts are Successful
9. Study examines dietary influences of liver disease
10. Study examines liver transplantation after drug induced acute liver failure
11. Study Supports Wider Use of Statins

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...TheAmericanSocietyofEchocardiography(ASE)hasreleas...0CMSPhysicianFeeSchedule(PFS)onpatientsandpractice...ndtechnicianssurveyed,87percentsaidthenewfeeschedu...ducestafforshutdowntheirpracticecompletely--ultima...ltrasound)andothervitalservices. ,, Onecardiacs...
(Date:11/24/2009)...tCall/--RegeneronPharmaceuticals,Inc.(Nasdaq: REGN...ffrayHealthcareConferenceonTuesday,December1,2009....hesessionmaybeaccessedthroughtheCompany,swebsite, ...chivedversionofthepresentationwillbeavailableafter...ormationaboutRegeneronandrecentnewsreleasesareavai...
(Date:11/24/2009)...eezing, study finds , , TUESDAY, Nov. 24...affic pollution and indoor endotoxin are at increa...in -- a component of bacteria believed to trigger ..., University of Cincinnati College of Medicine ...rning sign of asthma and other lung conditions) in...
(Date:11/24/2009)... likely to become disabled, study finds , ...hildren may slow the progression of multiple scler...hers followed 330 women who had experienced their ..., Women who had given birth to at least one chil...progress to a stage in which they needed walking a...
(Date:11/24/2009)...diaMediTechCompany,aleading,pharmaceuticalR&Do...thatthecompanyreceivedtheRedHerringAsiaTop100Enter...hnologycompaniesintheAsiaPacific,region. , Re...rvarious,regions,suchasNorthAmerica,Europe,andAsia...ttherequirementsofcutting-edgetechnology,andoutsta...
Breaking Medicine News(10 mins):Health News:Lives Compromised and Patient Access Limited with New Cuts to Medicare 2Health News:Traffic, Dust Linked to Asthma in Kids 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 2Health News:Childbirth May Slow Progression of Multiple Sclerosis 3
...n-anemic women between ages 18 and 55 with unexpla...d to women with low ferritin, a protein that store...leen. Researchers from the University of Lausan...decreased by 29 percent in the iron group compared...
...ntrol and Prevention has reported a global fall in...s a contagious disease and is the fifth leading ca...is has largely been possible due to improved vacci...t in the developing countries.// According to repo...
...ases Monday, the smallest number of new cases sinc...ports on the spread of the SARS epidemic last mont...in Beijing and Inner Mongolia, bringing China's de...w death and one// infection Monday. The epidemic h...
...ne that might be responsible for asthma. Scientist...g of the disease, hence leading to better treatme...ant effect on a person's susceptibility to asthma...some that was known to contain an asthma-related g...
...are often caused by bacteria and are frequently tr...Fluoroquinolones have been recommended empirical t... indicates that Ciprofloxacin has high activity ag...ly treatment option for these difficult-to treat i...
...ic illness could be triggered by abortion. However...ctic from the anti-abortion movement. Researchers ...ancies were more likely to be hospitalised for psy...who had an abortion were nearly three times more l...
Other Medicine News:
(Date:11/24/2009)...O,Nov.24/PRNewswire-FirstCall/--Orexigen®Ther...panyfocusedonthetreatmentofobesity,todayannouncedt...ompany,sBoardofDirectorsgrantedaninducementstockop...lassen,M.D.,itsnewlyappointedHeadoftheGlobalContra...entivestockoptiontotheextentpermittedbylawandhasan...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--KeryxBiopharmaceuti...ur,theCompany,sChiefExecutiveOfficer,isscheduledto...encebeingheldinNewYorkCity. ,, Mr.Bentsur,spres...10:30AMETandwillbeaccessiblefromtheInvestorInforma...eryx.com .Anarchivedversionofthewebcastwillbeavail...
(Date:11/23/2009)...ATI,Nov.23/PRNewswire-FirstCall/--HealthWarehouse....derpharmacy,todayannounceditsfinancialresultsforth...tedquarterlyrevenueof$1,006,721,drivenbyheavygrowt...insincreased13.0%year-over-yearto34.6%andthenetlos...299forthethreemonthsendedSeptember30,2008. ,, "...
Breaking Medicine Technology:Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3blue sky scrubs adds Caribbean Blue Scrubs 61357 1blue sky scrubs adds Caribbean Blue Scrubs 61357 2TET Systems and Novo Nordisk sign license agreement 10723 1TET Systems and Novo Nordisk sign license agreement 10723 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 1Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 3
... - New Study Demonstrated the Clinical Potential o...s, Which Were as Effective as,Avastin(R) in Animal...Newswire-FirstCall/ --,Peregrine Pharmaceuticals, ...developing targeted monoclonal antibodies,for the ...n, today,reported that data from multiple studies ...
... LOS ANGELES--(BUSINESS WIRE)--Apr 23, 2007 - CytR...he RNA interference (RNAi),delivery technology exc..., RXi Pharmaceuticals Corporation (RXi), has been,... scientific,journal ACS Chemical Biology. The tech... Advisory Board member and University of,Massachus...
Other Medicine Technology:Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 2Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 3Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 4Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 5Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 6Peregrine Pharmaceuticals Highlights Significant Advances in the,Company's Clinical and Preclinical Cancer Programs Presented This,Week at the AACR Annual Meeting 7CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 2CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 3CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively,Licensed to Subsidiary, RXi Pharmaceuticals, Described in,Peer-Reviewed Journal 4
Roche COMPACT 3 Blood Gas Analyzer
GEM® Premier™ 3000 with iQM™
ABL800 FLEX Blood Gas Analyzer
AGIT1006 Agitator
Medicine Products: